146 related articles for article (PubMed ID: 16038892)
1. Pharmacogenetic study of apolipoprotein E, cholesteryl ester transfer protein and hepatic lipase genes and simvastatin therapy in Brazilian subjects.
Fiegenbaum M; da Silveira FR; Van der Sand CR; Van der Sand LC; Ferreira ME; Pires RC; Hutz MH
Clin Chim Acta; 2005 Dec; 362(1-2):182-8. PubMed ID: 16038892
[TBL] [Abstract][Full Text] [Related]
2. The cholesteryl ester transfer protein Taq1B gene polymorphism predicts clinical benefit of statin therapy in patients with significant coronary artery disease.
Carlquist JF; Muhlestein JB; Horne BD; Hart NI; Bair TL; Molhuizen HO; Anderson JL
Am Heart J; 2003 Dec; 146(6):1007-14. PubMed ID: 14660992
[TBL] [Abstract][Full Text] [Related]
3. Interaction between a common variant of the cholesteryl ester transfer protein gene and the apolipoprotein E polymorphism: effects on plasma lipids and lipoproteins in a cohort of 7-year-old children.
Rump P; Mensink RP; Hornstra G
Nutr Metab Cardiovasc Dis; 2002 Dec; 12(6):317-24. PubMed ID: 12669678
[TBL] [Abstract][Full Text] [Related]
4. Association between cholesteryl ester transfer protein gene polymorphisms and variations in lipid levels in patients with coronary heart disease.
Zheng KQ; Zhang SZ; He Y; Zhang L; Zhang KL; Huang DJ; Sun Y
Chin Med J (Engl); 2004 Sep; 117(9):1288-92. PubMed ID: 15377415
[TBL] [Abstract][Full Text] [Related]
5. Cholesteryl ester transfer protein TaqIB polymorphism and its relation to parameters of the insulin resistance syndrome in an Austrian cohort.
Weitgasser R; Galvan G; Malaimare L; Derflinger I; Hedegger M; Lang J; Iglseder B; Ladurner G; Paulweber B
Biomed Pharmacother; 2004 Dec; 58(10):619-27. PubMed ID: 15589073
[TBL] [Abstract][Full Text] [Related]
6. TaqIB polymorphism in CETP gene: the influence on incidence of cardiovascular disease in statin-treated patients with familial hypercholesterolemia.
Mohrschladt MF; van der Sman-de Beer F; Hofman MK; van der Krabben M; Westendorp RG; Smelt AH
Eur J Hum Genet; 2005 Jul; 13(7):877-82. PubMed ID: 15856070
[TBL] [Abstract][Full Text] [Related]
7. [Study on the distribution and association of cholesteryl ester transfer protein-TaqIB polymorphism and plasma concentration in general population].
Liu J; Zhao D; Liu S; Liu J; Qin LP; Wu ZS
Zhonghua Liu Xing Bing Xue Za Zhi; 2003 Apr; 24(4):300-3. PubMed ID: 12820950
[TBL] [Abstract][Full Text] [Related]
8. The effect of APOE, CETP, and PCSK9 polymorphisms on simvastatin response in Thai hypercholesterolemic patients.
Wanmasae S; Sirintronsopon W; Porntadavity S; Jeenduang N
Cardiovasc Ther; 2017 Dec; 35(6):. PubMed ID: 28851085
[TBL] [Abstract][Full Text] [Related]
9. Human fasting plasma concentrations of vitamin E and carotenoids, and their association with genetic variants in apo C-III, cholesteryl ester transfer protein, hepatic lipase, intestinal fatty acid binding protein and microsomal triacylglycerol transfer protein.
Borel P; Moussa M; Reboul E; Lyan B; Defoort C; Vincent-Baudry S; Maillot M; Gastaldi M; Darmon M; Portugal H; Lairon D; Planells R
Br J Nutr; 2009 Mar; 101(5):680-7. PubMed ID: 18662427
[TBL] [Abstract][Full Text] [Related]
10. CETP (cholesteryl ester transfer protein) promoter -1337 C>T polymorphism protects against coronary atherosclerosis in Japanese patients with heterozygous familial hypercholesterolaemia.
Takata M; Inazu A; Katsuda S; Miwa K; Kawashiri MA; Nohara A; Higashikata T; Kobayashi J; Mabuchi H; Yamagishi M
Clin Sci (Lond); 2006 Nov; 111(5):325-31. PubMed ID: 16822236
[TBL] [Abstract][Full Text] [Related]
11. Plasma cholesteryl ester transfer protein concentrations predict cardiovascular events in patients with coronary artery disease treated with pravastatin.
Marschang P; Sandhofer A; Ritsch A; Fiŝer I; Kvas E; Patsch JR
J Intern Med; 2006 Aug; 260(2):151-9. PubMed ID: 16882279
[TBL] [Abstract][Full Text] [Related]
12. The cholesteryl ester transfer protein (CETP) TaqIB polymorphism in the cholesterol and recurrent events study: no interaction with the response to pravastatin therapy and no effects on cardiovascular outcome: a prospective analysis of the CETP TaqIB polymorphism on cardiovascular outcome and interaction with cholesterol-lowering therapy.
de Grooth GJ; Zerba KE; Huang SP; Tsuchihashi Z; Kirchgessner T; Belder R; Vishnupad P; Hu B; Klerkx AH; Zwinderman AH; Jukema JW; Sacks FM; Kastelein JJ; Kuivenhoven JA
J Am Coll Cardiol; 2004 Mar; 43(5):854-7. PubMed ID: 14998629
[TBL] [Abstract][Full Text] [Related]
13. Comparative effects of simvastatin and cholestyramine on plasma lipoproteins and CETP in humans.
McPherson R
Can J Clin Pharmacol; 1999; 6(2):85-90. PubMed ID: 10519734
[TBL] [Abstract][Full Text] [Related]
14. Genetic variation in the hepatic lipase gene is associated with combined hyperlipidemia, plasma lipid concentrations, and lipid-lowering drug response.
Cenarro A; Artieda M; Gonzalvo C; Meriño-Ibarra E; Arístegui R; Gañán A; Díaz C; Sol JM; Pocoví M; Civeira F;
Am Heart J; 2005 Dec; 150(6):1154-62. PubMed ID: 16338252
[TBL] [Abstract][Full Text] [Related]
15. An interaction between the TaqIB polymorphism of cholesterol ester transfer protein and smoking is associated with changes in plasma high-density lipoprotein cholesterol levels in Turks.
Hodoğlugil U; Williamson DW; Huang Y; Mahley RW
Clin Genet; 2005 Aug; 68(2):118-27. PubMed ID: 15996208
[TBL] [Abstract][Full Text] [Related]
16. Common variants of Cholesteryl ester transfer protein gene and their association with lipid parameters in healthy volunteers of Tamilian population.
Padmaja N; Ravindra Kumar M; Soya SS; Adithan C
Clin Chim Acta; 2007 Jan; 375(1-2):140-6. PubMed ID: 16890925
[TBL] [Abstract][Full Text] [Related]
17. [Relationship between gene polymorphism at CETP locus and hyperlipidemia in the middle-aged and the elder].
Zhao Y; Zhu W; Zhang Z; Li Y
Wei Sheng Yan Jiu; 2004 Jan; 33(1):94-7. PubMed ID: 15098490
[TBL] [Abstract][Full Text] [Related]
18. Haplotypes of the cholesteryl ester transfer protein gene predict lipid-modifying response to statin therapy.
Winkelmann BR; Hoffmann MM; Nauck M; Kumar AM; Nandabalan K; Judson RS; Boehm BO; Tall AR; Ruaño G; März W
Pharmacogenomics J; 2003; 3(5):284-96. PubMed ID: 14583798
[TBL] [Abstract][Full Text] [Related]
19. Cholesteryl ester transfer protein TaqIB variant, high-density lipoprotein cholesterol levels, cardiovascular risk, and efficacy of pravastatin treatment: individual patient meta-analysis of 13,677 subjects.
Boekholdt SM; Sacks FM; Jukema JW; Shepherd J; Freeman DJ; McMahon AD; Cambien F; Nicaud V; de Grooth GJ; Talmud PJ; Humphries SE; Miller GJ; Eiriksdottir G; Gudnason V; Kauma H; Kakko S; Savolainen MJ; Arca M; Montali A; Liu S; Lanz HJ; Zwinderman AH; Kuivenhoven JA; Kastelein JJ
Circulation; 2005 Jan; 111(3):278-87. PubMed ID: 15655129
[TBL] [Abstract][Full Text] [Related]
20. Effects of cholesteryl ester transfer protein TAQ1B polymorphism in renal transplant patients.
Zeybek U; Isbir T; Ergen HA; Yilmaz H; Hekim N; Akoglu E
Transplant Proc; 2006 Jun; 38(5):1382-4. PubMed ID: 16797310
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
